Toria / Shutterstock.com
On December 7, LSIPR will be hosting the Life Sciences Patents Network Europe 2016 at the Bloomsbury Hotel in London. Here we preview the main talking points.
Newton Media, the publisher of Life Sciences IP Review, is excited to host this publication’s first event. On December 7, 2016, the best and brightest people working in life sciences intellectual property, including in-house counsel and private practitioners, will converge on the Bloomsbury Hotel in London for a day of networking, education and debate.
So far, we have confirmed speakers from leading drugs companies Bayer, GSK, Novartis and Lundbeck, among others, and representatives from the European Patent Office and the European Commission will also be presenting.
We have attempted to cover as many important topics as possible in one day, but a couple stand out.
You need a subscription to continue reading this content.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Bayer, GSK, Novartis, Life Sciences Patents Network Europe 2016, supplementary protection certificates, generic, patent, life sciences,